Intra-Cellular Therapies to Host Virtual Annual Meeting of Stockholders
May 13 2020 - 4:15PM
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical
company focused on the development and commercialization of
therapeutics for central nervous system (CNS) disorders, today
announced that it will hold its 2020 Annual Meeting of Stockholders
(the “Annual Meeting”) virtually due to the public health impact of
the coronavirus (COVID-19) pandemic and to prioritize the health
and well-being of meeting participants.
The Annual Meeting will be held in a virtual-only format on May
27, 2020, at 10:00 a.m., Eastern Time. Stockholders will not be
able to attend the Annual Meeting in person, however, stockholders
of record and registered beneficial owners as of the close of
business on April 6, 2020, will be able to vote and ask questions
during the meeting through the online platform.
Attending the Virtual Annual Meeting
Stockholders can attend the meeting by accessing
www.meetingcenter.io/238568156 and entering the 15-digit control
number found on their proxy card, voting instruction form, notice
of internet availability of proxy materials, or email previously
received. Stockholders may vote during the Annual Meeting by
following the instructions available on the meeting website during
the meeting.
A support line will be available on the meeting website shortly
prior to, and during, the Annual Meeting to assist stockholders
with any technical difficulties they may have accessing or hearing
the virtual meeting.
Participating, Voting Electronically and Submitting
Questions at the Virtual Annual Meeting
Stockholders of Record
Stockholders of record will be able to participate in the Annual
Meeting, vote electronically and submit questions during the live
webcast of the meeting, without advance registration. The two items
of information needed to access the live webcast of the meeting are
the following:
Computershare Control Number: the 15-digit control number found
on your proxy card, voting instruction form, notice of internet
availability of proxy materials, or email you previously
received
Meeting password: ITCI2020
Beneficial Owners
If you are a beneficial owner and hold your shares through an
intermediary, such as a bank, broker or nominee, you must register
in advance to participate in the Annual Meeting, vote
electronically and submit questions during the live webcast of the
meeting. To register in advance you must obtain a legal proxy from
the bank, broker or other nominee that holds your shares giving you
the right to vote the shares. You must forward a copy of the legal
proxy along with your email address to Computershare Trust Company,
N.A. (“Computershare”).
Requests for registration should be directed to Computershare by
email at legalproxy@computershare.com no later than 10:00 a.m.
Eastern Time, on Tuesday, May 26, 2020. You will receive a
confirmation of your registration and instructions on how to attend
the meeting by email after Computershare receives your registration
materials.
Stockholders may also submit questions in advance of the Annual
Meeting by emailing your question, along with proof of ownership,
to ir@itci-inc.com. The Company will, subject to time constraints,
answer all questions that are pertinent to the business of the
Annual Meeting.
About Intra-Cellular TherapiesIntra-Cellular
Therapies is a biopharmaceutical company founded on Nobel
prize-winning research that allows it to understand how therapies
affect the inner-workings of cells in the body. The Company
leverages this intracellular approach to develop innovative
treatments for people living with complex psychiatric and
neurologic diseases. For more information, please visit
www.intracellulartherapies.com.
Contact
Intra-Cellular Therapies, Inc. Juan Sanchez, M.D. Vice
President, Corporate Communications and Investor Relations
646-440-9333
Burns McClellan, Inc. Lisa
Burnsjgrimaldi@burnsmc.com 212-213-0006
MEDIA INQUIRIES:
Ana Fullmer Corporate Media Relations
W2Owcgafullmer@wcgworld.com202-507-0130
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Sep 2023 to Sep 2024